Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Hyaluronic Acid Viscosupplementation Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Hyaluronic Acid Viscosupplementation Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Hyaluronic Acid Viscosupplementation Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Hyaluronic Acid Viscosupplementation Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 17 Feb 2020
  • Report ID: CMFE 0022
  • Pages:167
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

Hyaluronic Acid Viscosupplementation are anticipated to grow at a value CAGR of ~x% over 2019-2028. According to a study published by Insure Insights on the Hyaluronic Acid Viscosupplementation market is anticipated to gain popularity in the forecast period. The key factor propelling the industry includes, the growth in the diminishing lifestyles, which includes physical inactivity and the reduction of synovial fluid is anticipated to boost in the coming years. The growth in the healthcare spending would help the industry flourish in the near future.

Top Driver: Increase In the Awareness Programs to propel the industry

Hyaluronic Acid Viscosupplementation has rich demand in the developed and developing countries in the forecast period. This owes to the increase in the awareness programs by the various public-private organization and the government regarding the quality of life to be improves and hence is anticipated to help the industry grow in the coming years. The surge in the advancement of the products in period would also help the industry gain highest revenue shares in the near future. There is a growth in demand for minimally invasive surgical procedures which would help the industry gain higher revenue in the near future.

Hospitals to Make Crucial Contribution to Growth of Global Hyaluronic Acid Viscosupplementation Market

Among end user segments of the global Hyaluronic Acid Viscosupplementation market, hospitals are predicted to show significant growth in future. The hospitals have higher number of patient flow which would contribute to the growth of the industry during the forecast period. Furthermore, the rise in the investments over the research and development coupled with the increase in adoption of newer technologies would help the industry flourish in the coming years. The orthopedic Clinics would gain highest revenue due to increase in focus over the advanced technologies and hence would grow in the next few years.

Rising Investments to Benefit North America Market

North American countries such as the US are predicted to maximize their spending on technologies in future. This would contribute to the lucrative growth of the industry in the next few years. Furthermore, the rise in the investments on the research and development on the advancement of technologies would help the industry boost in the coming years. The surge in the disposable income of the population in the region is expected to help the industry flourish in the coming years. Asia Pacific region is also expected to grow due to the surge in population coupled with the surge in healthcare spending in the region.

Players to Focus on Hyaluronic Acid Viscosupplementation

The global Hyaluronic Acid Viscosupplementation market is expected to stay fragmented with the increase in the number of new entrants in the coming years. Anika Therapeutics, Bioventus, SynviscOne, Supartz, Q-Med, Stanford Chemicals, Carbylan Therapeutics, Croma-Pharma, Meda Pharma, TRB Chemedica, Swiss biomed Orthopaedics.

Anika Therapeutics: In 2014, Anika Therapeutics had received approval for its product MONOVISC. This is a single-injection type of hyaluronic acid viscosupplementation. Furthermore, another single-injection product CINGAL, from the same company was added in the pipeline, which is anticipated to fuel market growth in the coming years.

Zimmer Biomet: In November 2016, Zimmer Biomet had signed an exclusive distribution agreement with Seikagaku Corporation for the sales of VISCO-3 in the U.S. market. Zimmer Biomet also distributes Seikagaku Corporation’s Gel-One Cross-linked Hyaluronate product. This is anticipated to help the industry gain highest revenue shares in the forecast period.

Bioventus LLC: In February 2018, Bioventus LLC entered into an extension of its agreement with Seikagaku Corporation to continue the distribution and marketing of SUPARTZ FX in the U.S. This would help the players gain attention in the industry and hence propel the growth in the next few years.

Scope of the Report

By Type

  • Standard
  • Stabilized

By Application

  • Hip Arthritis
  • Ankle Arthritis
  • Knee Arthritis
  • Shoulder Arthritis

By End-User

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Care Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Hyaluronic Acid Viscosupplementation Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Hyaluronic Acid Viscosupplementation Market -Industry Snapshots

6.1             Overview

6.1.1          Global Hyaluronic Acid Viscosupplementation Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Hyaluronic Acid Viscosupplementation Market Analysis, by Type

7.1             Overview

7.2             Key Findings for Hyaluronic Acid Viscosupplementation Market- By Type

7.2.1          Hyaluronic Acid Viscosupplementation Market- Standard

7.2.2          Hyaluronic Acid Viscosupplementation Market- Stabilized

Chapter 8           Global Hyaluronic Acid Viscosupplementation Market Analysis, by Application

8.1             Overview

8.2             Key Findings for Hyaluronic Acid Viscosupplementation Market- By Application

8.2.1          Hyaluronic Acid Viscosupplementation Market- Hip Arthritis

8.2.2          Hyaluronic Acid Viscosupplementation Market- Ankle Arthritis

8.2.3          Hyaluronic Acid Viscosupplementation Market- Knee Arthritis

8.2.4          Hyaluronic Acid Viscosupplementation Market- Shoulder Arthritis

Chapter 9           Global Hyaluronic Acid Viscosupplementation Market Analysis, by End User

9.1             Overview

9.2             Key Findings for Hyaluronic Acid Viscosupplementation Market- By End User

9.2.1          Hyaluronic Acid Viscosupplementation Market- Hospitals

9.2.2          Hyaluronic Acid Viscosupplementation Market- Orthopaedic Clinics

9.2.3          Hyaluronic Acid Viscosupplementation Market- Ambulatory Care Centres

9.2.4          Hyaluronic Acid Viscosupplementation Market- Others

Chapter 10       Hyaluronic Acid Viscosupplementation Market Analysis by Region

10.1           Key Findings for Hyaluronic Acid Viscosupplementation Market- By region

10.2           Overview

10.2.1       Global Hyaluronic Acid Viscosupplementation Market Analysis, By Type, 2019 – 2028

10.2.2       Global Hyaluronic Acid Viscosupplementation Market Analysis, By Application, 2019 – 2028

10.2.3       Global Hyaluronic Acid Viscosupplementation Market Analysis, By End User, 2019 – 2028

10.3           Hyaluronic Acid Viscosupplementation Market – North America

10.3.1       Overview

10.3.2       U.S.

10.3.3       Canada

10.3.4       Mexico

10.3.5       North America Market, By Type

10.3.6       North America Market, By Application

10.3.7       North America Market, By End User

10.4           Hyaluronic Acid Viscosupplementation Market – Europe

10.4.1       Overview

10.4.2       Germany

10.4.3       United Kingdom

10.4.4       France

10.4.5       Italy

10.4.6       Rest Of Europe

10.4.7       Europe Market, By Type

10.4.8       Europe Market, By Application

10.4.9       Europe market by, End User

10.5           Hyaluronic Acid Viscosupplementation Market – Asia Pacific

10.5.1       Overview

10.5.2       China

10.5.3       Japan

10.5.4       India

10.5.5       Rest of APAC

10.5.6       Asia Pacific Market, By Type

10.5.7       Asia Pacific Market, By Application

10.5.8       Asia Pacific Market, By End User

10.6           Hyaluronic Acid Viscosupplementation Market – SAMEA

10.6.1       Overview

10.6.2       Middle East & Africa (MEA)

10.6.3       South America

10.6.4       Rest Of World

10.6.5       South America, Middle East and Africa Market, By Type

10.6.6       South America, Middle East and Africa Market, By Application

10.6.7       South America, Middle East and Africa Market, By End User

Chapter 11       Market Competition Analysis

11.1           Market Share/Positioning Analysis

11.1.1       Market Positioning of Key Vendors, 2019

11.1.2       Key Strategies Adopted by the Leading Players

11.1.3       Recent Developments

Chapter 12       Company Profiles- Snapshot

12.1           Anika Therapeutics

12.1.1       Business Fundamentals

12.1.2       Financial Snapshots

12.1.3       Product Portfolio

12.1.4       Recent Developments

12.2           Bioventus

12.3           SynviscOne

12.4           Supartz

12.5           Q-Med

12.6           Stanford Chemicals

12.7           Carbylan Therapeutics

12.8           Croma-Pharma

12.9           Meda Pharma

12.10        TRB Chemedica

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 13       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report